Autologous stem cell transplantation aids autoimmune patients by functional renewal and TCR diversification of regulatory T cells

Abstract excerpt

Autologous hematopoietic stem cell transplantation (HSCT) is increasingly considered for patients with severe autoimmune diseases whose prognosis is poor with standard treatments. Regulatory T cells (Tregs) are thought to be important for disease remission after HSCT. However, eliciting the role of donor and host Tregs in autologous HSCT is not possible in humans due to the autologous nature of the intervention....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to CAR-T cell therapy research
• Share to Diabetes and associated disorders
• Share to T-cell and B-cell Immunology